MENU
ARCT
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Arcturus Therapeutics Holdings (ARCT) Earnings Date & Reports

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases... Show more

A.I. Advisor
published Earnings

ARCT is expected to report earnings to fall 973.47% to $4.28 per share on March 02

Arcturus Therapeutics Holdings ARCT Stock Earnings Reports
Q4'25
Est.
$4.28
Q3'25
Missed
by $6.02
Q2'25
Missed
by $3.55
Q1'25
Missed
by $4.11
Q4'24
Missed
by $0.92
The last earnings report on November 10 showed earnings per share of -49 cents, missing the estimate of $5.53. With 355.65K shares outstanding, the current market capitalization sits at 187.10M.
View a ticker or compare two or three
ARCT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARCT showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of technology and therapeutics for rare diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
10628 Science Center Drive
Phone
+1 858 900-2660
Employees
180
Web
https://www.arcturusrx.com